2nd Quarter - Termination
CROSSROADS STRATEGIES, LLC for INSYS THERAPEUTICS, INC.
Client
Income
$30,000
Expenses
—
Terminated
Jun 30, 2017
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) scheduling issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT New | Legislative Director, Senior LA, LA, Staff Asst: Cong. Ed Whitfield |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.